Literature DB >> 9928997

Dermal fibroblast proliferation is improved by beta-catenin overexpression and inhibited by E-cadherin expression.

C Soler1, C Grangeasse, L G Baggetto, O Damour.   

Abstract

Several recent studies have shown that proteins of the cadherin-catenin complex are not only involved in cell-cell adhesion but also in the proliferation and differentiation processes. For the first time, we investigated the effect of the quantity of cytoplasmic beta-catenin on dermal fibroblast proliferation by overexpressing human beta-catenin in human dermal fibroblasts. Our results show that dermal fibroblasts overexpressing normal beta-catenin or a stabilized beta-catenin mutant have a higher growth rate than control fibroblasts. Moreover, when confluence is reached, the number of fibroblasts is increased when the cells overexpress beta-catenin suggesting a role for beta-catenin in the regulation of contact growth arrest. Finally, by comparing proliferation in normal dermal fibroblasts and dermal fibroblasts expressing E-cadherin we observed a negative regulatory effect of E-cadherin expression on fibroblast proliferation. These data demonstrate the involvement of beta-catenin and cadherin in the dermal fibroblast proliferation process and in contact growth arrest.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9928997     DOI: 10.1016/s0014-5793(98)01648-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  9 in total

1.  E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors.

Authors:  M Y Hsu; F E Meier; M Nesbit; J Y Hsu; P Van Belle; D E Elder; M Herlyn
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307

2.  Astroglial injury in an ex vivo model: contributions to its analysis in enriched cell cultures.

Authors:  Ximena A Lanosa; Jorge A Colombo
Journal:  In Vitro Cell Dev Biol Anim       Date:  2007-07-06       Impact factor: 2.416

3.  beta-Catenin stabilization dysregulates mesenchymal cell proliferation, motility, and invasiveness and causes aggressive fibromatosis and hyperplastic cutaneous wounds.

Authors:  Sophia S Cheon; Alexander Y L Cheah; Stefanie Turley; Puviindran Nadesan; Raymond Poon; Hans Clevers; Benjamin A Alman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-30       Impact factor: 11.205

4.  N-glycosylation gene DPAGT1 is a target of the Wnt/beta-catenin signaling pathway.

Authors:  Pritam K Sengupta; Meghan P Bouchie; Maria A Kukuruzinska
Journal:  J Biol Chem       Date:  2010-08-06       Impact factor: 5.157

5.  Downregulation of miRNAs during Delayed Wound Healing in Diabetes: Role of Dicer.

Authors:  Sushant Bhattacharya; Rangoli Aggarwal; Vijay Pal Singh; Srinivasan Ramachandran; Malabika Datta
Journal:  Mol Med       Date:  2015-11-19       Impact factor: 6.354

6.  Adherens junction proteins are expressed in collagen corneal equivalents produced in vitro with human cells.

Authors:  Claude J Giasson; Alexandre Deschambeault; Patrick Carrier; Lucie Germain
Journal:  Mol Vis       Date:  2014-03-29       Impact factor: 2.367

7.  Beta-catenin and transforming growth factor beta have distinct roles regulating fibroblast cell motility and the induction of collagen lattice contraction.

Authors:  Raymond Poon; Saeid Amini Nik; Jessica Ahn; Laura Slade; Benjamin A Alman
Journal:  BMC Cell Biol       Date:  2009-05-11       Impact factor: 4.241

8.  Equine CTNNB1 and PECAM1 nucleotide structure and expression analyses in an experimental model of normal and pathological wound repair.

Authors:  Vincenzo Miragliotta; Zoë Ipiña; Josiane Lefebvre-Lavoie; Jacques G Lussier; Christine L Theoret
Journal:  BMC Physiol       Date:  2008-01-31

9.  Dermal fibroblasts induce cell cycle arrest and block epithelial-mesenchymal transition to inhibit the early stage melanoma development.

Authors:  Linli Zhou; Kun Yang; R Randall Wickett; Yuhang Zhang
Journal:  Cancer Med       Date:  2016-04-06       Impact factor: 4.452

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.